(Q46341880)

English

Pharmacokinetics of oral posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.

scientific article published in October 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Pharmacokinetics of oral posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Oliver A Cornely

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Gopal Krishna

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Malaz AbuTarif

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Fengjuan Xuan

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Monika Martinho

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

David Angulo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

0 references

publication date

1 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1223-1232

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Towards a targeted, risk-based, antifungal strategy in neutropenic patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Posaconazole as salvage therapy for zygomycosis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteers

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Effects of age, gender, and race/ethnicity on the pharmacokinetics of posaconazole in healthy volunteers

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Posaconazole plasma concentrations in juvenile patients with invasive fungal infection

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil).

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Posaconazole pharmacokinetics, safety, and tolerability in subjects with varying degrees of chronic renal disease

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Adjunctive Therapy of Allergic Bronchopulmonary Aspergillosis with Itraconazole

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1223

21 January 2018

Identifiers

10.1592/PHCO.28.10.1223

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823218%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46341880&oldid=1543950549"